04, 2025 (GLOBE NEWSWIRE) -- Noom , the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today announced the launch of the Noom Microdose GLP-1 Rx Program, a groundbreaking offering designed to unlock weight loss and long-term health benefits while minimizing side effects through personalized microdoses of GLP-1 medication, when clinically appropriate
"Oftentimes, patients will say that seeing that kind of image is what not only motivates them to lose weight, but can also be what tells them that their body has started to change as they lose the weight," he says
Am J Cardiol 2014;114:384-8.ArticlePubMed 123
Loose caps : Always replace the pen cap after each injection to protect the medication from light exposure
These risks highlight the importance of professional guidance
Drink enough fluids: hydration matters, especially with vomiting or diarrhea